July 3, 2025 AABB: Ray Goodrich wins 2025 Dale Smith Memorial Award

CSU Professor Ray Goodrich won the award for the development and implementation of pathogen-reduction technology.
May 21, 2025 AUTM: Personalized Cancer Treatment: How Colorado State University is Changing the Future of Care

CSU Professor Ray Goodrich and his lab are developing a new immunotherapy approach to treat cancer.
May 15, 2025 OEDIT Announces Grants to 35 Colorado Startups and Researchers in the Advanced Industries

Dr. Ray Goodrich is a recipient of a grant from OEDIT to develop a device for treating blood products to prevent the transfusion of transmitted diseases.
March 22, 2021 Coronavirus vaccines are rolling out across the world. So why are CSU scientists still working to develop new ones?

Researchers at Colorado State University with Ray Goodrich are working on four COVID-19 vaccine candidates, one of which is nearing human clinical trials.
February 5, 2021 Researchers turn to proven process for ASF vaccine development

Ray Goodrich partners with Okoth to create an inactivated ASF vaccine that maintains the structure of the virus as close to the natural pathogen as possible.
September 21, 2020 CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

A research team led by Ray Goodrich was awarded a $3.1 million base contract to continue development of a coronavirus vaccine candidate known as SolaVAX™.
May 31, 2020 Scientists develop method to reduce coronavirus count in plasma, blood products

Ray Goodrich develops the Mirasol Pathogen Reduction Technology System, a device which may help lower the possibility of COVID-19 transmission via blood transfusion.
April 12, 2020 Colorado scientists pivot to join worldwide pursuit of coronavirus vaccine

Researchers led by Ray Goodrich focus on probiotics, ultraviolet light and vitamin B2 in developing vaccine candidates for coronavirus.

March 26, 2020 Colorado State University researchers developing coronavirus disinfectant spray

CSU engineering students and faculty use science from vaccine research led by Ray Goodrich to develop a disinfectant to kill coronavirus on surfaces.
1 2